EUVIMEDEUVIMED entdecken
Crossref

Evaluation of the Eosin‐5′‐Maleimide Flow Cytometry Test for the Diagnosis of Hereditary Spherocytosis

Pablo Adrian Biaggioni iD, Alejandro Ceferino López Romero

European Journal of Haematology · 2026

DOI: 10.1111/ejh.70204 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Haematology, 2026. Verfasst von Pablo Adrian Biaggioni und 1 weiteren Autor:innen. Beteiligte Einrichtung: Hematology Department and Teaching Department, IACA Laboratorios, Bahía Blanca, Argentina. Hauptthemen laut MEDLINE: Spherocytosis, Hereditary, Flow Cytometry, Eosine Yellowish-(YS). Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 18 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Hereditary spherocytosis (HS) is a congenital hemolytic anemia caused by erythrocyte membrane protein defects. While the eosin‐5′‐maleimide (EMA) binding test by flow cytometry is the established first‐line assay, this study evaluates its optimal cut‐offs and performance within a large, real‐world cohort.

Methods

We retrospectively analyzed 181 consecutive samples (2017–2024) with suspected HS. EMA binding was performed by flow cytometry using conventional and standardized protocols; the latter (implemented in 2023) utilized fixed erythrocyte counts and FL1 bead calibration. Accuracy was assessed against a composite clinical–laboratory reference standard. ROC analysis determined sensitivity, specificity, likelihood ratios, and AUC.

Results

HS was confirmed in 50/181 cases (27.6%). EMA fluorescence reduction was significantly greater in HS (median 23.0%) than in non‐HS samples (9.0%). The optimal cut‐off (16.5%) yielded 96.0% sensitivity, 96.9% specificity, and AUC = 0.990 (95% CI 0.979–0.998). Both conventional and standardized protocols showed equivalent accuracy (AUC 0.988 vs. 0.992). False positives were mainly associated with severe microcytosis or autoimmune hemolytic anemia.

Conclusions

In a consecutive, real‐world cohort of patients with suspected hereditary spherocytosis referred to a single reference laboratory receiving samples from across the country, the EMA test demonstrated high diagnostic accuracy consistent with previous reports. Importantly, implementation of a standardized protocol resolved reproducibility issues in fluorescence intensity measurement without compromising diagnostic performance, supporting its robustness and applicability in routine clinical laboratories.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Spherocytosis, HereditaryFlow CytometryEosine Yellowish-(YS)HumansFemaleMaleRetrospective StudiesChild, PreschoolChildInfantAdultROC CurveSensitivity and SpecificityReproducibility of ResultsAdolescent

Stichwörter der Autor:innen

diagnostic accuracyeosin‐5′‐maleimideflow cytometryhereditary spherocytosisred blood cell membrane disordersstandardization

Substanzen

Eosine Yellowish-(YS)eosin maleimide

Autor:innen und Institutionen

  • Hematology Department and Teaching Department, IACA Laboratorios, Bahía Blanca, Argentina.
  • Hematology Department, IACA Laboratorios, Bahía Blanca, Argentina.

ORCID-Profile: Pablo Adrian Biaggioni

Zitieren

APA

Biaggioni, P. A., & López Romero, A. C. (2026). Evaluation of the Eosin‐5′‐Maleimide Flow Cytometry Test for the Diagnosis of Hereditary Spherocytosis. European Journal of Haematology. https://doi.org/10.1111/ejh.70204

Vancouver

Biaggioni PA, López Romero AC. Evaluation of the Eosin‐5′‐Maleimide Flow Cytometry Test for the Diagnosis of Hereditary Spherocytosis. European Journal of Haematology. 2026. doi:10.1111/ejh.70204

BibTeX
@article{Biaggioni2026,
  author = {Biaggioni, Pablo Adrian and López Romero, Alejandro Ceferino},
  title = {Evaluation of the Eosin‐5′‐Maleimide Flow Cytometry Test for the Diagnosis of Hereditary Spherocytosis},
  journal = {European Journal of Haematology},
  year = {2026},
  doi = {10.1111/ejh.70204}
}
Kostenlos starten →